TCR-Therapy Pipeline Research Report 2023: Comprehensive Insights on 30+ Companies and 100+ Pipeline Drugs
22 nov. 2023 08h48 HE
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "TCR-Therapy - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Exploring CAR-T Therapy: A New Era in Cancer Treatment
14 nov. 2023 04h48 HE
|
Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "CAR-T Therapy- Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. The research report delves into several...
Analysis of the Cell Therapy Technologies Industry, 2023-2028: Increasing Partnerships for the Development of Cell Therapies, Emerging Asian Markets
30 août 2023 06h03 HE
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global landscape of cell...
Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board
23 févr. 2023 04h00 HE
|
AKAMPION
- Leading European T cell therapy researcher adds further scientific expertise ROTTERDAM, February 23, 2023 - Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery...
Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer
17 janv. 2023 04h00 HE
|
AKAMPION
- Strengthening of T cell research expertise to develop next-generation T cell therapies for patients with limited or no treatment options ROTTERDAM, January 17, 2023 - Pan Cancer T B.V., a...
Chimeric Antigen Receptor CAR T Cell Therapy Cancer Treatment Market Size Report
25 juin 2022 02h34 HE
|
KuicK Research
Singapore, June 25, 2022 (GLOBE NEWSWIRE) -- Global CAR T Cell Therapy Market & Clinical Trials Insight 2028 Report Highlights: Research MethodologyGlobal CAR T Cell Therapy Market Opportunity...
INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT
16 juin 2022 09h00 HE
|
Invectys, Inc.
HOUSTON, June 16, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the Cell Therapy Manufacturing Center (CTMC), a joint venture between...